Dr. Naoko Takebe
Claim this profileNational Institutes of Health Clinical Center
Studies Cancer
Studies Tumors
7 reported clinical trials
13 drugs studied
Area of expertise
1Cancer
Stage IV
PIK3CB positive
PTEN positive
2Tumors
Stage IV
PIK3CB positive
PTEN positive
Affiliated Hospitals
Clinical Trials Naoko Takebe is currently running
Atezolizumab + Tiragolumab
for Rare Cancers
This trial tests if the combination of atezolizumab and tiragolumab can help treat patients with advanced rare solid tumors. Atezolizumab is a type of drug that helps the immune system fight cancer. These drugs aim to boost the immune system to fight cancer more effectively. The study will also collect samples to understand how the treatment works and who might benefit most from it.
Recruiting1 award Phase 2
Pelcitoclax + Cobimetinib
for Recurrent Ovarian and Endometrial Cancers
This trial tests the safety and best dose of two drugs, pelcitoclax and cobimetinib, in patients with recurring ovarian and endometrial cancers. Pelcitoclax helps kill cancer cells, and cobimetinib slows their growth. The goal is to find an effective dose and observe how well the combination works in shrinking or stabilizing tumors.
Recruiting1 award Phase 117 criteria
More about Naoko Takebe
Clinical Trial Related7 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Naoko Takebe has experience with
- Nivolumab
- Ipilimumab
- Atezolizumab
- Tiragolumab
- PI3Kbeta Inhibitor AZD8186
- Docetaxel
Breakdown of trials Naoko Takebe has run
Cancer
Tumors
Ovarian Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Naoko Takebe specialize in?
Naoko Takebe focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are PIK3CB positive.
Is Naoko Takebe currently recruiting for clinical trials?
Yes, Naoko Takebe is currently recruiting for 3 clinical trials in Bethesda Maryland. If you're interested in participating, you should apply.
Are there any treatments that Naoko Takebe has studied deeply?
Yes, Naoko Takebe has studied treatments such as Nivolumab, Ipilimumab, Atezolizumab.
What is the best way to schedule an appointment with Naoko Takebe?
Apply for one of the trials that Naoko Takebe is conducting.
What is the office address of Naoko Takebe?
The office of Naoko Takebe is located at: National Institutes of Health Clinical Center, Bethesda, Maryland 20892 United States. This is the address for their practice at the National Institutes of Health Clinical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.